Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes (Q27689597)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes
scientific article

    Statements

    Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes (English)
    0 references
    Tesfaye Biftu
    0 references
    Ranabir Sinha-Roy
    0 references
    Ping Chen
    0 references
    Xiaoxia Qian
    0 references
    Dennis Feng
    0 references
    Jeffrey T Kuethe
    0 references
    Ying Duo Gao
    0 references
    Youwei Yan
    0 references
    Davida Krueger
    0 references
    Annette Bak
    0 references
    George Eiermann
    0 references
    Jiafang He
    0 references
    Jason Cox
    0 references
    Jacqueline Hicks
    0 references
    Kathy Lyons
    0 references
    Huaibing He
    0 references
    Gino Salituro
    0 references
    Sharon Tong
    0 references
    Sangita Patel
    0 references
    George Doss
    0 references
    Aleksandr Petrov
    0 references
    Joseph Wu
    0 references
    Shiyao Sherrie Xu
    0 references
    Charles Sewall
    0 references
    Xiaoping Zhang
    0 references
    Bei Zhang
    0 references
    Nancy A Thornberry
    0 references
    Ann E Weber
    0 references
    24 April 2014
    0 references
    57
    0 references
    8
    0 references
    3205-12
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit